India Conducts Over 20L COVID-19 Tests, Highest Ever In Single-Day: Govt
Mumbai: The Ministry of Health and Family Welfare (MoHFW) said on Monday that more than 20 lakh COVID-19 tests were conducted in the last 24 hours, the highest in a day in India.
The ministry said in a release that in continuation of the positive trend, less than 3 lakh new cases were reported in India for three consecutive days and the positivity rate in the country came down to 13.31 per cent.
“20.08 lakh trials conducted in the last 24 hours in the country are also a global record. More than 32 crore trials have been conducted across the country so far. A total of 2,67,334 new cases were reported in the last 24 hours.”
The number of people who get cured daily for the sixth consecutive day is more than new cases daily. 3,89,851 recoveries were recorded in the last 24 hours. India’s cumulative recovery has reached 2,19,86,363 today. The national recovery rate has increased to 86.23 per cent,” the release said.
Also Read: Man Held For Extorting Money From Girls, Threatening: Delhi Police
The ministry said that 10 states in the country registered 74.46 per cent new cases in the last 24 hours, and Tamil Nadu recorded the highest number of 33,059 new cases, followed by Kerala with 31,337 new cases.
On the other front, the minister said that India’s total active caseload has come down to 32,26,719 today, with a net decline of 1,27,046 cases in the last 24 hours.
Also Read: Girl Hangs Self At Teacher’s Home After He Sexually Assaults Her In Assam
According to MoHFW, the cumulative number of COVID-19 vaccine doses administered in the country under the third phase of the nationwide vaccination campaign has reached 18.58 crore today.
“A total of 18,58,09,302 vaccine doses have been administered through 27,10,934 sessions, as per the provisional report till 7 am today. These include 96,73,684 HCWs who have taken the 1st dose and 66,59,125 HCWs who have taken the 2nd dose, 1,45,69,669 FLWs (1st dose), 82,36,515FLWs (2nd dose), 64,77,443beneficiaries under 18-44 age group (1st dose), 5,80,46,339 (1st dose) and 93,51,036 (2nd dose) beneficiaries aged 45 to 60 years. 5,48,16,767 1st dose beneficiaries and 1,79,78,724 2nd dose beneficiaries of more than 60 years old,” it added.
Follow us on Twitter, Instagram, and like us on Facebook for the latest updates and interesting stories.
